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Bacterial artiﬁcial chromosome (BAC) technology has contributed immensely to manipulation of larger genomes in many
organismsincludinglargeDNAviruseslikehumancytomegalovirus(HCMV).TheHCMVBACclonepropagatedandmaintained
inside E. coli allows for accurate recombinant virus generation. Using this system, we have generated a panel of HCMV deletion
mutants and their rescue clones. In this paper, we describe the construction of HCMV BAC mutants using a homologous
recombination system. A gene capture method, or gap repair cloning, to seize large fragments of DNA from the virus BAC in
order to generate rescue viruses, is described in detail. Construction of rescue clones using gap repair cloning is highly eﬃcient
and provides a novel use of the homologous recombination-based method in E. coli for molecular cloning, known colloquially
as recombineering, when rescuing large BAC deletions. This method of excising large fragments of DNA provides important
prospects for in vitro homologous recombination for genetic cloning.
1.Introduction
Human cytomegalovirus (HCMV), also known as human
herpesvirus-5, belongs to the betaherpesvirinae subfamily of
the herpesviridae family. The virus is ubiquitously found in
all geographic locations and among diﬀerent socioeconomic
groups with seroprevalence up to 90% [1]. Though a
large percentage of the human population is infected with
this virus, it does not cause signiﬁcant clinical illness in
immunocompetent individuals; however, high mortality and
morbidityrateisfoundinimmunocompromisedindividuals
such as AIDS patients, transplant recipients, newborns, and
developing fetuses [1]. Like other herpesviruses, this virus
also retains the ability to remain latent in its host for life
[2]. The virus can infect many diﬀerent cell types including
epithelial cells, endothelial cells, monocytes, macrophages,
ﬁbroblasts, smooth muscle cells, and neurons [1]. The virus
is transmitted among individuals via bodily ﬂuids, prenatal
exposure, and sexual contact [2].
The HCMV genome is the largest and most complex
among human herpesviruses, with 200–235kb nucleotide
pairs encoding for more than 200 proteins [3]. The virus
genome encodes 40 herpesvirus core proteins and the rest
of the genes encode betaherpesvirus virus-speciﬁc protein or
HCMV-speciﬁc proteins. At present, the function of all of
the viral genes has not been fully understood. One method
for studying gene function is to delete a speciﬁc gene and
study the mutant virus phenotype in the host. Due to the
large genome size of HCMV, making recombinant virus is a
challenging and cumbersome task; as a result, the functional
study of many viral genes is hindered.
Several approaches have been used for the construction
of recombinant HCMV. One of the earlier methods was
to transfect human permissive cell lines with virus genome
along with a plasmid carrying a marker gene with long
ﬂanking homology to the viral region to be modiﬁed into
a host cell and then selecting for recombinants [4]. Some
of the drawbacks in this method were: (1) the primary2 Journal of Biomedicine and Biotechnology
permissive cells are diﬃcult to transfect and the probability
of getting both the viral genome and the plasmid in the same
cell was low; (2) eﬃciency of homologous recombination
was low and long homology sequences (over 500bp) are
required; (3) replication cycle of the virus was slow and
selecting a recombinant virus took a few days, and (4)
the recombinant viruses and parental viruses were mixed
and therefore isolation of the recombinant virus required
extensive plaque puriﬁcation. However, the development of
a cosmid system did lead to a better method for construction
of recombinants [5–7]. Manipulation of the viral genome
could be done in one of the cosmids and cotransfection of
this mutated cosmid along with other wild-type cosmids in
a permissive cell would give rise to recombinant virus upon
homologous recombination [5, 7]. Although the cosmid
method was an improvement, it was far from perfect as
HCMV has a large genome and a total of eight cosmids
were required for recombinant generation [5]. This does not
seem to be a problem intuitively, but the resultant virus from
this method of mutagenesis would be the product of several
recombination events that are not only diﬃcult to control,
but veriﬁcation of the viral genome can only be done after
growth and isolation of the mutant virus, leading to a great
deal of lost time and eﬀort if all of the recombination events
did not occur properly.
Overcoming the aforementioned diﬃculties, the devel-
opment of the bacterial artiﬁcial chromosome clone (BAC)
of the virus was a breakthrough in the HCMV mutagenesis
ﬁeld. The HCMV BAC clone can be maintained stably and
propagated inside a bacterial cell, which allows for easy
manipulation of the viral genome. Any required mutation
can easily be achieved inside the E. coli cell and this mutation
can be veriﬁed before making recombinant virus. Recombi-
nantvirusescanbemaderapidlyandstraightforwardlywhen
utilizing BAC genetic methods of manipulation. The ﬁrst
CMV BAC was made by using the murine cytomegalovirus
(MCMV) Smith strain by Messerle et al. in 1997 [6]. Shortly
after the construction of the MCMV BAC, Borst et al.
described the construction of ﬁrst HCMV BAC clone using
the AD169 strain of the virus [8]. Recombinant viruses were
made inside a CBTS E. coli strain, which carries a recA
amber allele and a temperature-sensitive amber suppressor,
so that the cells are recA positive at 30◦Ca n drecA negative at
temperatureshigherthan37◦C[8].TheCBTSE.colicarrying
the virus BAC were transformed with a shuttle plasmid
containing virus sequence with desired modiﬁcation and
upon homologous recombination, the altered virus sequence
replaced the wild-type sequence from the BAC, resulting in
recombinant BAC clones. The recombinant BAC was then
veriﬁed, isolated, and transfected into mammalian cells in
order to generate recombinant virus. Since the development
of this novel method for construction of recombinant
viruses, detailed functional study of virus genome has been
done using the BAC mutagenesis approach [3, 9–11].
However,themethodsforBACmutagenesisweusetoday
were not at ﬁrst easily attained as the large size of BACs
posed a serious obstacle for their exact manipulation, as is
required for viral research. Techniques were developed that
utilized the power of homologous recombination in order
to create recombinant viruses with the ability to safeguard
every step in the process. We can now replace, and therefore
delete large DNA fragments by inserting antibiotic resistance
markers for proper and accurate selection of recombinant
BAC clones and insert a luciferase reporter gene in order
to measure expression of the recombinant virus. These
new systems circumvented the problems associated with
conventional genetic engineering as there was no longer
a size restriction as seen when using restriction enzymes
or other previous methods [12, 13]. Various modiﬁcations
have been made to increase the eﬃcacy of the homologous
recombination-based method forthe constructionof recom-
binant viruses. This method is known as recombineering,
or, less colloquially, the recombination-mediated genetic
engineering method in E. coli that uses the recombination
proteins derived from λ phage [13]. Discussed below are the
methods commonly used to make recombinant clones via
this method.
2. Uses of Recombination-Mediated Genetically
EngineeredBACsinViralResearch
2.1. Construction of Deletion Mutants. Several diﬀerent
approaches have been utilized to make deletion clones of
HCMV using the BAC clone. Use of site-directed mutagen-
esis in E. coli using positive and negative selection markers
is a common method of making recombinants. The virus
BAC is maintained inside a modiﬁed DH10B strain of E.
coli such as DY380 or SW102, which are recA negative
and harbor repressed λ prophage recombination systems.
The recombination system consists of exo, bet, and gam
genes and is under the control of temperature-sensitive
cI repressor protein [12, 13]. A generalized summary of
the straightforward procedure of using this recombination
system in E. coli to generate deletion mutant BACs is given in
Figure 1. When using a positive selection marker to replace
a region of interest (ROI) by homologous recombination
(Figure 1), the marker is usually a PCR-ampliﬁed antibiotic
resistant gene, kanamycin-resistant gene in this case (a),
containing short ﬂanking homology to the region of interest
to be deleted that was conferred by primer design (b). The
recombination system of the E. coli harboring target DNA
(d) can be induced, only when required, by inactivating the
repressor protein by incubating the bacteria at 42◦Cf o r1 5
minutes during electrocompetent cell preparation (e). The
kanamycin cassette is transformed into electrocompetent
and recombination-activated E. coli, in this case DY380 with
its recombination system induced, harboring the wild-type
virus BAC (f). The recombinants produced by homologous
recombination event (g) are selected in the presence of
kanamycin, which allows for the growth of only the clones
containing the kanamycin resistant gene. Advantage of this
method is that two genes can be deleted sequentially using
two diﬀerent drug resistance markers [14].
The second approach, which makes use of a positive and
counterselection protocol, utilizes the SW105 (or SW102 or
SW106) strain of E. coli, which is derived from the DY380
strain [15]. The SW105 strain contains the same λ prophageJournal of Biomedicine and Biotechnology 3
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Figure 1: Toledo ROI Deletion Mutant BAC Clone Generation. A kanamycin resistant gene (a) is ampliﬁed by primers containing 40-
bp homology to the sequences ﬂanking the region of interest (ROI) in Toledo BAC (b) to create the kanamycin resistant cassette (c). In
order to generate an ROI deletion mutant BAC clone (ROI Δ), DY380 E. coli carrying WT Toledo BAC (d) must undergo electrocompetent
cell preparation and induction for recombination gene expression (e). The kanamycin resistant cassette is then electroporated into the
electrocompetent DY380 harboring WT Toledo BAC (f). Upon homologous recombination, the ROI will be replaced by the kanamycin
resistant gene, generating the Toledo ROI Δ mutant BAC clone (g).
recombination system as DY380, but the major diﬀerence
is that the SW105 contains a galactose operon in which
the galactokinase (galK) gene is defective, so when SW105
bacteria are incubated on minimal media with galactose as
thesolesourceofcarbon,thebacteriacannotgrow.However,
when the galK gene is provided in trans, it will complement
the defective galK gene, thus allowing the bacteria to grow
in minimal media with galactose. When making deletion
mutants using this approach, instead of a cassette conferring
drug resistance, a PCR-ampliﬁed galK gene is used to replace
the gene of interest by homologous recombination. The
bacteria containing the correct deletion clones are selected
on minimal media with galactose, where positive growth
indicates the presence of the inserted galK gene. Colonies
are further veriﬁed by growing them on MacConkey agar,
wheretheclonescontainingthegalK geneproducedarkpink
colonies [15].
2.2. Construction of Rescue Clones. When making rescue or
mutant clones by a positive selection method that takes
advantage of homologous recombination in DY380, ﬁrst
the gene of interest is deleted by recombination with the
antibiotic resistant cassette methods discussed above. Next,
the gene is cloned from WT BAC and mutated (if making
a point, frameshift, or nonsense mutation) either by PCR
in which the primers confer the mutation, or via site-
directed mutagenesis. The mutated gene is cloned into a
plasmid either upstream or downstream of a drug resistance
gene for positive selection (Note: antibiotic-resistant gene
must be diﬀerent than the gene used to construct the dele-
tion mutant). The gene antibiotic-resistant cassette is then
ampliﬁed by PCR using primers containing homology arms
ﬂanking the BAC genetic locus. The homologous sequences
can be as short as 40bp. The cassette is transformed into
bacteria that contain the gene deletion virus BAC clone,
and the resulting recombinant clones are selected using the
new drug resistance gene marker. The clones can be further
veriﬁed by conﬁrming their sensitivity to the previous drug
used to make the deletion. The drawback of this method is
that the virus genome will contain a drug resistance gene.
To improve the shortcomings of this method, the drug
resistance gene can be ﬂanked with loxP sites, which can
be removed by addition of cre during transfection of the
recombinantBACDNAintomammaliancells.Thiswillleave
only 34bp loxP site in the mutant BAC clone and virus [16].
When making rescue clones in SW105 using the galK
counterselection marker method, the WT gene or mutated
gene is PCR ampliﬁed along with the homology arms
ﬂanking the BAC genetic locus. This PCR cassette is
electroporated into electrocompetent and recombination-
activated SW105 harboring the deletion mutant BAC, and by
homologous recombination, the galK gene will be replaced
by the WT or mutated gene from the cassette. The recom-
binants are selected in minimal media containing 2-DOG
and glycerol. The bacteria that contain galK genes will be
unable to grow due to the toxic metabolites released from 2-
DOGmetabolism, whereasthe clones in whichthe galK gene
has been replaced by the wild-type or the mutated sequence4 Journal of Biomedicine and Biotechnology
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Figure 2: Gene Capture Method. (a) Linearized plasmid vector (b) is ampliﬁed by primers containing homology arms to the sequences
ﬂanking the region of interest (ROI) in Toledo to create the plasmid vector cassette (c). Electrocompetent and recombination-activated
DY380 harboring WT Toledo BAC (d) are used for electroporation with the plasmid vector cassette (e). Upon homologous recombination
and circularization, the ROI is captured, creating the ROI rescue plasmid (f).
will survive using glycerol as the source of carbon [15]. This
method has advantages over the ﬁrst one in that the rescue
clones do not contain any foreign sequences in the viral BAC
clone, hence in the virus. Even though this method is more
advantageous over the previous one, making rescue clones in
t h i sm a n n e ri ss t i l lad i ﬃcult process.
As simple as the previously cited methods sound, they
are equally unsuitable when making rescue clones of large
deletion mutants such as a 6-kb deletion, due to the
requirement of PCR ampliﬁcation of the region. In order
to bypass the size restriction of PCR, a slightly diﬀerent
approach to making rescue clones of a large fragment
deletion mutant (15-kb) was used by Wang et al. [17]. Since
the 15-kb region in WT BAC DNA was ﬂanked by two
EcoRI restriction enzyme sites, the BAC DNA was digested
by EcoRI and separated on the gel. From the gel, an 18-
kb size product, which contains the 15-kb region fragment
with 1.5-kb homology arms on either side, was extracted and
transformed into the DY380 E. coli containing the deletion
mutant BAC. It was possible to use this method because the
deletedregionwasﬂankedbyrestrictionenzymesitesinsuch
a way that it provided long homology arms at both ends
of the region of interest. The applicability of this method
depends entirely upon the presence of restriction enzyme
sites ﬂanking the gene/region of interest. When working
with large DNA like HCMV BAC, it is likely not to have
suitable enzyme sites ﬂanking the gene/region of interest.
Furthermore,evenifrestrictionenzymesitesﬂanktheregion
appropriately, there could be additional restriction sites in
other locations of the viral genome, resulting in the digested
band of interest in the gel containing multiple diﬀerent
species of DNA fragments.
To resolve the issues associated with each of the methods
described above, a gene capture method was developed and
usedforthe ﬁrsttime torescuealarge15-kb deletion mutant
HCMV BAC [18]. This approach utilizes the principle of
gap repair cloning in yeast with modiﬁcation. Gap repair
cloning is a commonly used method to repair double-strand
breaks in yeast. This method has been described as the most
eﬃcient and error proof method of cloning [19]. It was
shown that the plasmid was integrated into the chromosome
if a crossover event was followed by the gap repair, whereas
nonintegrated plasmid with repaired double-stranded break
was the result of no crossover event [19] .A ss m a l la s3 0 - b p
homology arms have been shown to be suﬃcient for eﬃcient
gap repair cloning [20]. A modiﬁcation of the method was to
u s eo l i g o n u c l e o t i d el i n k e r sa sh o m o l o g ya r m ss ot h a tu n i q u e
restriction enzyme sites can be added to the vector plasmid
along with the oligonucleotide arms [21].
When making rescue clones by this gene capture method
using DY380 containing the wild-type virus BAC (Figure 2),
ﬁrst the region of interest (ROI) is deleted by the above-
mentioned method in DY380, generating an ROI deletion
mutant. Next, a linearized plasmid (a) containing a pos-
itive selection marker is ampliﬁed by PCR with primers
containing homologous sequences ﬂanking the ROI in the
BAC (b). In order to facilitate screening of rescue clones,
a gene providing resistance to an antibiotic diﬀerent than
the antibiotic markers in both the BAC and rescue plasmid,
ﬂankedwithloxPsites,isinsertedwithinthecapturedROIby
homologous recombination. The PCR-ampliﬁed cassette (c)
is transformed into electrocompetent and recombination-
activated DY380 harboring the virus BAC (d). By homol-
ogous recombination, the ROI will be captured into theJournal of Biomedicine and Biotechnology 5
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Figure 3: Toledo ROI Rescue BAC Clone Construction. Since the ROI rescue plasmid contains restriction enzyme sites (a), the plasmid is
digested by restriction endonucleases (b), leading to isolation of the rescue cassette (c). Electrocompetent and recombination-activated
DY380 harboring the ROI Δ mutant Toledo BAC (d) are used for electroporation with the rescue cassette (e). Upon homologous
recombination, the ROI is inserted into the ROI Δ mutant Toledo BAC, generating the ROI-Rescued Toledo BAC (f).
plasmid due to gap repair cloning (e). These recombinant
clones are selected using the drug resistance marker gene on
the plasmid (Note: the plasmid antibiotic resistance should
be separate than the antibiotic resistance of the BAC). This
capturecanbefurtherveriﬁedbyamplifyinganopenreading
frame within the ROI by PCR and also by digesting the
plasmid with restriction enzymes to check for the presence
of the captured region.
Figure 3 provides the method for generating the rescued
BAC clone after ROI capture. First, the plasmid containing
the ROI (a) is digested by speciﬁc restriction enzymes with
recognition sites ﬂanking the region of interest (b). This
rescue cassette (c) is then electroporated into electrocom-
petent and recombination-activated DY380 (d) containing
the ROI deletion BAC (e). By homologous recombination,
the rescue cassette will be inserted into the ROI deletion
BAC, replacing the gene conferring kanamycin resistance,
and thereby generating a rescued BAC clone (f). Since the
ROI contains an antibiotic resistance marker diﬀerent than
that in the BAC, the clones are screened for resistance to that
antibiotic in LB agar. The rescue clones can be conﬁrmed
further by verifying sensitivity to the previous antibiotic
resistance (kanamycin) used to make the deletion.
It is important to note the subtle yet signiﬁcant diﬀer-
ences between the insertion of a cassette into the BAC DNA
for creation of a deletion of mutant and the excision, or
capture, of a DNA fragment from the BAC vector into a
plasmid for rescue virus generation. As shown in Figure 4,
directly after PCR ampliﬁcation, the homology arms of
the plasmid vector cassette are oriented diﬀerently than
the cassette for deletion mutant construction. The forward
primer sequence that generates the positive marker cassette
with homology for the ROI ﬂanking sequences in the BAC
is the same sequence oriented in the same direction as the
coding sequence upstream of the ROI. However, the reverse
primer used in this positive marker cassette generation
needs to be the reverse complement of the downstream
coding sequence as to allow for proper insertion required for
deletion mutant generation (a). The slight but compulsory
variance between insertion and capture lies in the fact that
during PCR ampliﬁcation of the plasmid vector cassette, the
template is linear, whereas when it is electroporated into E.
coli for gene capture, the plasmid vector cassette becomes
circular and the homology arms invert (b). This inversion
necessitatestheforwardprimertobethereversecomplement
sequence of the upstream homology region coding sequence,
and the reverse primer to be identical to the coding sequence
downstream of the ROI in sequence and in orientation. This
inversion needs to be taken into careful consideration when
designing suitable primers for the gene capture method to
work properly.
3.Speciﬁc Recombineering Methods in
ConstructionofRescueBACClone
3.1. Construction of 6-kb Region IV Deletion Mutant. We
deleted a 6-kb region (UL132–151, referred to as region IV
hereafter) from wild-type (WT) Toledo BAC by replacing
it with a positive antibiotic selection marker. A kanamycin
cassette with added homology arms ﬂanking the region
IV of Toledo BAC DNA was PCR ampliﬁed from pGEM-
oriV/kan1 plasmid using Hotstar Taq polymerase (Qia-
gen Company, CA). Forward and reverse primers for6 Journal of Biomedicine and Biotechnology
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Figure 4: Variation in Gene Capture Method Recombineering. (a) Orientation of homology arms in generation of deletion mutant BAC
clone. (b) Variant orientation of homology arms in linearized plasmid cassette for generation of plasmid with ROI captured.
kanamycin cassette were designed with 20-bp sequences
from the kanamycin resistance gene and 40 bases homol-
ogous nucleotide sequences ﬂanking region IV (Table 1).
The ampliﬁed kanamycin cassette was treated overnight with
DpnI restriction endonuclease (New England Biolab, MA) to
digest any template plasmid and then puriﬁed using Qiagen’s
PCR puriﬁcation kit (Qiagen, CA). The kanamycin cassette
was used to replace region IV in the Toledo BAC. 300ng of
the puriﬁed cassette was transformed into electrocompetent
DY380cellscarryingWTToledoBAC.Duringelectrocompe-
tent DY380 cell preparation, the λ prophage recombination
system in the cells was induced by incubating the bacteria
in a 42◦C water bath for 15 minutes with vigorous shaking.
The presence of λ recombination proteins in the E. coli
strainpreventsdegradationoftheelectroporatedlinearDNA
cassette and allows for homologous recombination [13].
T h et r a n s f o r m e dc e l l sw e r eg r o w na t3 2 ◦Co nL Ba g a r
with kanamycin (30μg/mL). Colonies were restreaked onto
LB agar with ampicillin (100μg/mL) and LB agar with
kanamycin plates, respectively, to conﬁrm the antibiotic
resistance of the colonies and since the kanamycin cassette
was ampliﬁed from pGEM-oriV/kan1 plasmid containing an
ampicillin resistance gene, the colonies were screened for
ampicillin sensitivity in order to prevent selection of clones
containing the pGEM-oriV/kan1 plasmid. The colonies that
were sensitive to ampicillin and resistant to kanamycin were
used for minipreparation. Miniprep of the BAC DNA was
done as described by Zhang et al. [14]. After conﬁrmation
of the deletion mutant BAC, a maxiprep of the bacteria using
NucleoBond BAC Maxi kit (BD Biosciences, CA) extracted
the Toledo Region IV deletion (IV-Δ) mutant BAC DNA
from the E. coli on a large scale. Deletion was once more
veriﬁed by PCR and integrity of the region IV-Δ BAC DNA
was analyzed by restriction endonuclease digestion with
EcoRI (New England Biolab, MA) and compared with the
digestion pattern of Toledo BAC DNA.
3.2. Construction of Rescue Clone through Gene Capture.
RegionIVwasclonedintoalinearizedrescuevector(pUC19)
with ﬂanking homology arms, as previously described by
gene capture, and the captured fragment was then put back
into the region IV-Δ BAC from the rescue vector. In order
to facilitate screening of rescue clones, a zeocin resistance
gene ﬂanked with loxP sites was inserted between ORF
UL149 and UL130 region, which is included in the region IV
ROI, by homologous recombination. The zeocin resistance
gene, along with the ﬂanking loxP sites, was ampliﬁed from
pGEM-lox-zeo plasmid by PCR. The primers contained
40-bp homology ﬂanking the BAC DNA locus where the
gene was inserted (Table 1). The PCR product was treated
with DpnI, as mentioned before, to remove the template
plasmid and then gel puriﬁed using Qiagen’s gel puriﬁcation
kit (Qiagen Company, CA). ∼300ng of the puriﬁed PCR
product was electroporated into recombination-activated
electrocompetent DY380 cells harboring WT Toledo BAC.
The colonies were grown on LB agar with zeocin (50μg/mL)
andtheinsertionofthezeocinresistancegenewasconﬁrmed
by PCR (Figure 5).
Region IV was captured into a rescue vector, pUC19,
a l o n gw i t ha ne x t r a1 5 0 b ps e q u e n c e sa te a c he n dt h a t
were used as homology arms. To capture the region IV
DNA fragment, the rescue plasmid was ﬁrst linearized by
BamHI digestion and ampliﬁed using primers containing
homology ﬂanking region IV (Table 1). Since the large size
of the region being captured did not possess adequate
restriction enzyme sites for digestion, unique restriction sites
for AscI (upstream) and FseI (downstream) were addedJournal of Biomedicine and Biotechnology 7
Table 1:TableofprimersusedforPCR.ToledoUL132KanFandToledoUL151KanR:primerstoamplifykanR cassetteforinsertionofpositive
antibiotic selection marker and simultaneous deletion mutant construction. ZeoInsertF and ZeoInsertR: ampliﬁcation of zeoR cassette for
insertion of positive antibiotic selection marker insertion within region IV between UL 130 and UL 149. pUC19-IVCap F and pUC19-
IVCap R: ampliﬁcation of plasmid cassette for region IV capture for rescue clone construction.
Primer Sequence (5  → 3 ) Function of primers
ToledoUL132KanF CGCGGACATAGCAAGAAATCCA
Amplify kanRcassette for
antibiotic selection and
region IV deletion
mutant construction
CGTCGCCACATCTCGAGAGCTCT
TGTTGGCTAGTGCGTA
ToledoUL151KanR CGACCAGCGCTTTGTGCGCGCT
GCCTGTGCGTGTCGTCCCTCTGC
CAGTGTTACAACCAA
ZeoInsertF GTCCGGCAGGATAGCGGTTAAG
Amplify zeoR cassette for
antibiotic selection
within region IV
between UL 130 and UL
149
GATTCGGTGCTAAGGCCGCATG
GCCGCGGATGGATCC
ZeoInsertR TATCTGCGTGGGTCTAATCATGG
GTGTCACCGTGATCGCGGCCGC
ACTAGTGATAGATCT
pUC19-IVCap F CATTCAGGCGCGCCGGTAGTGT
Amplify plasmid cassette
for region IV capture
into puc19 plasmid for
rescue clone generation
GTACAAAGGGAGGCGTGCTCAC
GGCCCGCAACCCGGGTACCGAG
CTCGAAT
pUC19-IVCap R TACTCAGGCCGGCCATCAAAAC
GCGAGCCCATATCGCCGCCATC
ATTGTAATCAGATGTGTGAAATT
GTTATCC
to the ends of the region via these primers. The PCR
product with the homology arms was puriﬁed and 300ng
of the puriﬁed PCR cassette was electroporated into DY380
carrying WT Toledo BAC with zeocin inserted into region
IV. The transformed cells were grown overnight at 32◦Co n
LB agar with zeocin and ampicillin. The colonies grown were
picked from the LB agar plate and cultured overnight in
5mL of LB with zeocin and ampicillin. Miniprep of pUC19-
IV capture plasmid isolated and puriﬁed the DNA from the
overnight culture using Qiagen’s miniprep kit (Qiagen, CA).
The captured region IV DNA fragment was conﬁrmed by
antibiotic selection and veriﬁed by PCR ampliﬁcation of the
ﬁrst (UL132) ORF, the second to last (UL150) ORF, another
ORF outside of region IV as a negative control (UL147), and
zeocin resistance gene was veriﬁed as a positive control for
capture (Figure 5). The plasmid was then digested with AscI
and FseI restriction enzymes to separate the vector sequence
from the region IV ROI. 500ng of the puriﬁed digestion
product (the rescue cassette) was transformed into DY380
carrying the Toledo IV-Δ mutant BAC by electroporation
and the transformants were cultured on LB agar with zeocin
and hygromycin (50μg/mL). The resulting colonies were
restreaked onto LB agar with either kanamycin or zeocin.
Thecoloniesthatgrewonlyonzeocin,andnotonkanamycin
plates, were used for miniprep. Region IV rescue (IV-R) BAC
DNA was used for PCR veriﬁcation along with WT and IV-Δ
BACs (Figure 6). The IV-R BAC was also digested by EcoRI
to check the integrity of the BAC DNA.
In order to produce mutant and rescue Toledo viruses,
∼3–5μg of the respective BAC DNA was electroporated
into MRC-5 cells along with pCDNA-71 (pp71 expressing
plasmid) and pGS403Cre (Cre expressing plasmid). The
pp71 protein is a viral transactivator and is used to enhance
viral growth [22]. The Cre protein is a recombinase that is
usedtoremovetheloxPﬂankingBACvectorandzeocingene
from the viral genome [16]. The electroporation conditions
used were 260V, 975μF and time constant of ≤50ms. MRC-
5 cells electroporated with the IV-R BAC were grown in a
10-cm cell culture dish and split when cells reached 100%
conﬂuency, with wild-type BAC used as a control. Six-
to-eight days following transfection, plaques with similar
growth kinetics and characteristics were observed from both
WT and rescue BAC DNA, indicating that the recombinant,
deletion-rescuedBACDNAwasasinfectiousasthewild-type
BAC.
4. Discussion
BAC cloning technique of viral genome has been a useful
tool, especially for mutagenesis studies of large DNA viruses
such as HCMV, in which the BAC DNA has been used
to mutate or delete the individual genes to understand
their functions in viral replications. Its greatest usefulness
was marked by studies in which viral gene functions were
screened at global scale for both MCMV and HCMV [6, 9,
10]. HCMV BAC DNAs of several clinical and attenuated8 Journal of Biomedicine and Biotechnology
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Figure 6: 1% Agarose gel electrophoresis of ORF targeted ampliﬁcation reactions in WT Toledo BAC (WT), Region IV Deletion Mutant
BAC (IV-Δ), and Region IV Rescued BAC (IV-R). Lane 1: 1kb Plus DNA ladder. Lanes 2–4: ampliﬁcation of UL 132 (∼850 bases) with UL
132 F and R primers. Lanes 5–7: ampliﬁcation of UL 151 (∼1100kb) with UL 151 F and R primers. Lanes 8–10: ampliﬁcation of UL 148
(∼1100 bases) with UL 148 F and R primers (positive control outside of region for deletion).
strains have been generated so that the genomic DNA
can be propagated and sustained inside an E. coli host
[3, 23]. The cloning technique using BAC DNA has several
modiﬁcations over traditional cloning such as (1) using E.
coli strains containing λ recombination proteins to enhance
homologous recombination eﬃciency [12, 24–27]; (2) using
cre/lox system so that extra DNA segments can be removed
when making viruses using BAC DNA [15]; (3) inserting
luciferase gene in the viral genome so that viral growth
curve experiments can be more reproducible and less time
consuming [12, 14, 17, 22]. These modiﬁcations have made
BAC cloning easier and more eﬃcient than before.
So far, most mutagenesis studies using the BAC system
requiregenerationofarescuecloneofthemutationtoassure
that no mutations occur anywhere other than the target
site. The procedure of making rescue BAC DNA requiresJournal of Biomedicine and Biotechnology 9
an original DNA fragment to be inserted back into the
viral genome. This can be achieved by PCR ampliﬁcation of
the DNA fragment along with homology arms ﬂanking the
mutated region and insertion of the ampliﬁed fragment back
into the mutant genome by homologous recombination. If
theDNAfragmentwerelargerthanthePCRlimit,diﬃculties
would arise in two aspects: (1) it is not easy to amplify;
and (2) even if it is possible to be synthesized by currently
available speciﬁc polymerases, the errors in DNA sequences
are still unavoidable. To solve this problem, we have utilized
the gap repair cloning method in BACs and modiﬁed it for
the purpose of generating rescue BAC clones in a method
calledgenecapture.AlthoughthegaprepairmethodofBACs
has been utilized in yeast [19–21]a n dE. coli [13, 24–27], it
has not been optimized for viral BACs in order to generate
rescue viruses. It was ﬁrst accomplished in HCMV when we
presented the rescue of a 15-kb deletion BAC clone by the
gene capture method, previously unattainable with the then
current methods of PCR-based ampliﬁcation of the region of
interest for generation of rescue virus BAC clones [18]. It has
herebeenpresentedasanoptimizedgenecapturemethodfor
rescuing the region IV deletion mutant HCMV Toledo BAC
clonewithmore practicalmethods that canbeapplied across
many ﬁelds. By capturing the region IV DNA fragment into
the rescue vector and putting it back into the mutant BAC,
we successfully rescued the region IV deletion in HCMV
genome. This gene capture method has three advantages: (1)
no PCR was needed so that possible mutations induced by
PCR can be avoided; (2) cloning of large DNA segments can
be accomplished in only one step with high eﬃciency; and
(3) diﬀerent selection markers can be used during each step
to ensure a higher cloning eﬃciency.
An additional advantage of the gene capture method
is that it provides ﬂexibility for the selection of the rescue
vector. Any commercial or lab constructed plasmid can be
used as a vector for capture. However, smaller plasmids are
desirable,astheyneedtobePCRampliﬁedwithhomologous
regions for the capture method to proceed. As a proof of
principle, we used a commonly available pUC19 plasmid as
a rescue vector and successfully captured region IV from
Toledo BAC. While choosing the vector plasmid, unique
restrictionsitesﬂankingthecapturegenearedesirable.Those
sites are later required to separate the captured region from
the plasmid backbone for rescue cassette isolation and rescue
procedure. If there are no unique restriction sites in the
plasmid, they can be added while amplifying the plasmid via
PCR primers, as was done in this case.
Previously,whengeneratinga15-kbrescuevirus,weused
homology arms of more than 1-kb on each side [18]. After
this study, it has been shown that the size of the homology
arms can be much smaller, which will reduce the total size
of the rescue plasmid. In the case of this region IV deletion
rescue, we used homology arms of 150-bp on each side of
the rescue cassette, a signiﬁcant improvement over the 1.5-
kb arms used previously.
In summary, this enhanced gene capture method allows
for easy cloning of large DNA fragments, previously a
dubious practice when done by PCR, which can be used to
rescue large deletions from any genome. By using region IV,
a 6-kb DNA piece from HCMV genome as an example, we
have demonstrated that the gene capture method is eﬃcient
and easier to perform than ever before for the construction
of rescue clones from large deletion fragment mutants.
5. FutureDirections
The potential for this method is undoubted, as it is not
limited to just HCMV and can be used for mutagenesis
study of other large DNA viruses as well as other organisms.
Furthermore, the prospects of using the homologous recom-
bination system in vitro for methods like gene capture has
numerous applications, the extent of its reach has yet to be
calculated in genetic and molecular cloning.
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region IV-R: region IV rescued clone.
Author’s Contribution
K. Dulal and B. Silver contributed equally to this work.
References
[1] E. Mocarski, Cytomegaloviruses and Their Replication, in Fields
Virology, Lippincott Williams & Wilkins, Philadelphia, Pa,
USA, 2007.
[2] J. Sinclair and P. Sissons, “Latency and reactivation of human
cytomegalovirus,” Journal of General Virology, vol. 87, part 7,
pp. 1763–1779, 2006.
[3] E. Murphy, D. Yu, J. Grimwood et al., “Coding potential of
laboratory and clinical strains of human cytomegalovirus,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 100, no. 25, pp. 14976–14981, 2003.
[4] R. R. Spaete and E. S. Mocarski, “Insertion and deletion muta-
genesis of the human cytomegalovirus genome,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 84, no. 20, pp. 7213–7217, 1987.
[ 5 ] G .K e m b l e ,G .D u k e ,R .W i n t e r ,a n dR .S p a e t e ,“ D e ﬁ n e dl a r g e -
scale alteration of the human cytomegalovirus genome con-
structed by cotransfection of overlapping cosmids,” Journal of
Virology, vol. 70, no. 3, pp. 2044–2048, 1996.
[6] M. Messerle, I. Crnkovic, W. Hammerschmidt, H. Ziegler, and
U.H.Koszinowski,“Cloningandmutagenesisofaherpesvirus
genome as an infectious bacterial artiﬁcial chromosome,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 94, no. 26, pp. 14759–14763, 1997.
[7] M. van Zijl, W. Quint, J. Briaire, T. De Rover, A. Gielkens, and
A. Berns, “Regeneration of herpesviruses from molecularly
clonedsubgenomicfragments,”JournalofVirology,vol.62,no.
6, pp. 2191–2195, 1988.10 Journal of Biomedicine and Biotechnology
[8] E. M. Borst, G. Hahn, U. H. Koszinowski, and M. Messerle,
“Cloning of the human cytomegalovirus (HCMV) genome as
an infectious bacterial artiﬁcial chromosome in Escherichia
coli: a new approach for construction of HCMV mutants,”
Journal of Virology, vol. 73, no. 10, pp. 8320–8329, 1999.
[9] W. Dunn, C. Chou, H. Li et al., “Functional proﬁling of a
human cytomegalovirus genome,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 100,
no. 2, pp. 14223–14228, 2003.
[10] D. Yu, M. C. Silva, and T. Shenk, “Functional map of
human cytomegalovirus AD169 deﬁned by global mutational
analysis,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 100, no. 21, pp. 12396–12401,
2003.
[11] A. Dolan, C. Cunningham, R. D. Hector et al., “Genetic
content of wild-type human cytomegalovirus,” Journal of
General Virology, vol. 85, part 5, pp. 1301–1312, 2004.
[ 1 2 ]D .Y u ,H .M .E l l i s ,E .C .L e e ,N .A .J e n k i n s ,N .G .C o p e l a n d ,
a n dD .L .C o u r t ,“ A ne ﬃcient recombination system for
chromosome engineering in Escherichia coli,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 97, no. 11, pp. 5978–5983, 2000.
[13] Y. Zhang, J. P. P. Muyrers, G. Testa, and A. F. Stewart, “DNA
cloning by homologous recombination in Escherichia coli,”
Nature Biotechnology, vol. 18, no. 12, pp. 1314–1317, 2000.
[14] Z. Zhang, Y. Huang, and H. Zhu, “A highly eﬃcient protocol
of generating and analyzing VZV ORF deletion mutants based
on a newly developed luciferase VZV BAC system,” Journal of
Virological Methods, vol. 148, no. 1-2, pp. 197–204, 2008.
[ 1 5 ]S .W a r m i n g ,N .C o s t a n t i n o ,D .L .C o u r t ,N .A .J e n k i n s ,
and N. G. Copeland, “Simple and highly eﬃcient BAC
recombineering using galK selection,” Nucleic Acids Research,
vol. 33, no. 4, p. e36, 2005.
[16] P. K. Stricklett, R. D. Nelson, and D. E. Kohan, “The Cre/loxP
system and gene targeting in the kidney,” American Journal of
Physiology, vol. 276, no. 5, part 2, pp. F651–F657, 1999.
[17] W. Wang, S. L. Taylor, S. A. Leisenfelder et al., “Human
cytomegalovirus genes in the 15-kilobase region are required
for viral replication in implanted human tissues in SCID
mice,” Journal of Virology, vol. 79, no. 4, pp. 2115–2123, 2005.
[18] K. Dulal, Z. Zhang, and H. Zhu, “Development of a gene
capture method to rescue a large deletion mutant of human
cytomegalovirus,” Journal of Virological Methods, vol. 157, no.
2, pp. 180–187, 2009.
[19] T. L. Orr-Weaver and J. W. Szostak, “Yeast recombination: the
association between double-strand gap repair and crossing-
over,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 80, no. 14, pp. 4417–4421, 1983.
[20] S. B. Hua, M. Qiu, E. Chan, L. Zhu, and Y. Luo, “Minimum
length of sequence homology required for in vivo cloning by
homologous recombination in yeast,” Plasmid, vol. 38, no. 2,
pp. 91–96, 1997.
[21] A. A. Kitazono, “Improved gap-repair cloning method that
uses oligonucleotides to target cognate sequences,” Yeast, vol.
26, no. 9, pp. 497–505, 2009.
[22] C. J. Baldick Jr., A. Marchini, C. E. Patterson, and T. Shenk,
“Human cytomegalovirus tegument protein pp71 (ppUL82)
enhances the infectivity of viral DNA and accelerates the
infectious cycle,” Journal of Virology, vol. 71, no. 6, pp. 4400–
4408, 1997.
[23] A. Marchini, H. Liu, and H. Zhu, “Human cytomegalovirus
with IE-2 (UL122) deleted fails to express early lytic genes,”
Journal of Virology, vol. 75, no. 4, pp. 1870–1878, 2001.
[24] D. L. Court, J. A. Sawitzke, and L. C. Thomason,
“Genetic engineering using homologous recombination,”
Annual Review of Genetics, vol. 36, pp. 361–388, 2002.
[25] L. Thomason, D. L. Court, M. Bubunenko et al., “Recom-
bineering: genetic engineering in bacteria using homologous
recombination,” in Current Protocols in Molecular Biology,M .
Ausubel et al., Ed., chapter 1, unit 1.16, John Wiley & Sons,
New York, NY, USA, 2007.
[26] S. K. Sharan, L. C. Thomason, S. G. Kuznetsov, and D. L.
Court,“Recombineering:ahomologousrecombination-based
method of genetic engineering,” Nature Protocols,v o l .4 ,n o .2 ,
pp. 206–223, 2009.
[27] K. Narayanan and Q. Chen, “Bacterial artiﬁcial chromosome
mutagenesis using recombineering,” Journal of Biomedicine
and Biotechnology, vol. 2011, Article ID 971296, 10 pages,
2011.